The global skin excision market involves the removal of skin lesions and tumors by surgical excision. Skin excision procedures provide an accurate diagnosis and effective treatment of skin cancers and lesions. Advancements in minimally invasive surgical equipment have decreased procedure time and risks of complications. The market offers devices such as shave biopsy blades, punches, bistouries, and scalpels optimized for smooth and precise excision of skin lesions and tumors with minimal damage to surrounding tissues.

The global skin excision market is estimated to be valued at US$ 29.90 billion in 2024 and is expected to exhibit a CAGR of 8.9% over the forecast period 2024 to 2031.

Rapid improvements in healthcare infrastructure, growing awareness regarding skin cancer diagnosis and treatment, and expanding access to medical insurance are anticipated to spur the demand for skin excision procedures. Additionally, the rising occurrence of melanoma and non-melanoma skin cancers owing to increasing UV exposure from the sun and tanning beds is anticipated to drive market growth.

Key Takeaways

Key players operating in the Global Skin Excision Market Growth are Ethicon Inc., Richard Wolf GMBH, Becton, Dickinson and Company, Integra LifeSciences, Exsurco Medical, Limbs & Things LTD, KARL STORZ GmbH & Co. KG, Aesculap, Inc., Medtronic, Zimmer Biomet, B. Braun SE, Conmed Corporation, Symmetry Surgical Inc., and Surtex Instruments Limited. These companies are focusing on new product launches and geographical expansions to consolidate their market position.

Get More Insights On- Global Skin Excision Market